Sigma Planning Corp - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sigma Planning Corp ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2021$80,000
-20.8%
73,000
+32.0%
0.00%
-33.3%
Q3 2021$101,000
+140.5%
55,310
+230.2%
0.00%
+200.0%
Q4 2020$42,000
-26.3%
16,750
-25.4%
0.00%
-50.0%
Q3 2020$57,000
-1.7%
22,450
+26.5%
0.00%
-33.3%
Q2 2020$58,000
+81.2%
17,750
+36.5%
0.00%
+50.0%
Q1 2020$32,000
-80.0%
13,000
-52.5%
0.00%
-75.0%
Q2 2019$160,00027,3800.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
Pathway Financial Advisors LLC 30,000$20,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders